Treatment of acute myeloid leukemia in older adults: time to reflect?
Ravandi
Farhad
F
Department of Leukemia, The University of Texas - MD Anderson Cancer Center, Houston, TX 77030, USA. fravandi@mdanderson.org
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001706:Biopsy; D001854:Bone Marrow Cells / Q000378:metabolism; D003561:Cytarabine / Q000008:administration & dosage*; D018572:Disease-Free Survival; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D016130:Immunophenotyping; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000473:pathology*; D008942:Mitoxantrone / Q000008:administration & dosage*; D012074:Remission Induction; D016896:Treatment Outcome
D003561:Cytarabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D008942:Mitoxantrone